PET/CT in Prostate Cancer

Häftad, Engelska, 2017

Del i serien Clinicians’ Guides to Radionuclide Hybrid Imaging

713 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

This pocket book explains the significant and well-documented impact that PET/CT can have on the management of prostate cancer through the provision of high-quality evidence regarding function and structure.

Produktinformation

Utgivningsdatum:2017-08-07
Mått:155 x 235 x 5 mm
Vikt:145 g
Format:Häftad
Språk:Engelska
Serie:Clinicians’ Guides to Radionuclide Hybrid Imaging
Antal sidor:60
Förlag:Springer International Publishing AG
ISBN:9783319576237

Utforska kategorier

Onkologi inom Medicin
Nuklearmedicin inom Medicin

Mer om författaren

Gary Cook is Professor of PET Imaging in the King’s College London and Guy’s & St Thomas’ PET Centre, the head of the Cancer Imaging Department in the Division of Imaging Sciences and Biomedical Engineering, King’s College London, and an honorary consultant at Guy’s & St Thomas’ Hospitals, London, UK. He is a member of the Guy’s and St Thomas’ Hospitals prostate cancer multidisciplinary team, imaging lead for the King’s Health Partners Prostate Cancer Research group, and a member of the UK National Cancer Research Institute Prostate Cancer Clinical Studies Group.

Recensioner i media

“This 76-page volume on PETCT in prostate cancer gives a high level overview of the various PET tracers in clinical use for the imaging of prostate cancer. The text is clear, concise and easy to understand. Images are of high quality and lend support to the text to illustrate key learning points. ... this book gives a useful overview of the state of PETCT imaging in prostate cancer.” (Henry Tam, RAD Magazine, June, 2018)

Innehållsförteckning

Epidemiology and Clinical Features of Prostate cancer.- Pathology of prostate cancer.- Management of Prostate Cancer.- Prostate cancer: Radiological Imaging.- The Role of PET/CT in Prostate Cancer Management.- Role of radiolabelled small molecules binding to PSMA in diagnosis and therapy of prostate cancer.- PET/CT in radiotherapy planning: current evidence in prostate cancer.